Abstract
Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Current Clinical Pharmacology
Title: Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy
Volume: 4 Issue: 2
Author(s): Vardan K. Gasparyan
Affiliation:
Abstract: Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Export Options
About this article
Cite this article as:
Gasparyan K. Vardan, Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy, Current Clinical Pharmacology 2009; 4(2) . https://dx.doi.org/10.2174/157488409788184954
DOI https://dx.doi.org/10.2174/157488409788184954 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Meet Our Regional Editor
Current Topics in Medicinal Chemistry Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients
Current Cancer Drug Targets Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Current Pharmaceutical Design The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia
Current Topics in Medicinal Chemistry Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens
Current Pharmacogenomics and Personalized Medicine The Role of Mast Cells in the Structural Alterations of the Airways as a Potential Mechanism in the Pathogenesis of Severe Asthma
Current Pharmaceutical Design What We have Learned about Pain from Rodent Models of Arthritis?
Current Rheumatology Reviews Analysis of TLC-Bioautography and TLC-Spot Visualization of <i>Atropa accuminata</i> and <i>Atropa belladonna</i> Extracts as Antioxidant and Antibacterial Agents Against Human Pathogenic Bacteria
Current Pharmaceutical Analysis PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Isothymusin, a Potential Inhibitor of Cancer Cell Proliferation: An In Silico and In Vitro Investigation
Current Topics in Medicinal Chemistry Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Treatment Outcome of Three Female Adolescents with Borderline Personality Disorder
Adolescent Psychiatry Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets Approaches to Gastrointestinal Cytoprotection: From Isolated Cells, Via Animal Experiments to Healthy Human Subjects and Patients with Different Gastrointestinal Disorders
Current Pharmaceutical Design Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
Current Medicinal Chemistry Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry Amberlyst-15® in PEG-400: Green Synthesis of 3-Benzoyl-5-Hydroxy Benzofuran and Naphtho[1,2-b]furan Derivatives at Room Temperature
Letters in Organic Chemistry Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells
Current Pharmaceutical Biotechnology Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
Current Medicinal Chemistry Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers
Current Medicinal Chemistry